BDBM50191137 CHEMBL212943::sodium 2-(3-(((1S,2R)-2-(4,5-diphenyloxazol-2-yl)cyclohexyl)methyl)phenoxy)acetate
SMILES: [O-]C(=O)COc1cccc(C[C@@H]2CCCC[C@H]2c2nc(c(o2)-c2ccccc2)-c2ccccc2)c1
InChI Key: InChIKey=OLFPZLNUGARNGY-AZGAKELHSA-M
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prostanoid IP receptor (Homo sapiens (Human)) | BDBM50191137 (CHEMBL212943 | sodium 2-(3-(((1S,2R)-2-(4,5-diphen...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 114 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL | Assay Description Agonist activity at human PGI2 receptor assessed as inhibition of ADP-induced platelet aggregation | Bioorg Med Chem Lett 16: 4861-4 (2006) Article DOI: 10.1016/j.bmcl.2006.06.076 BindingDB Entry DOI: 10.7270/Q2R49QD9 | |||||||||||
More data for this Ligand-Target Pair |